Meeting on the Mesa 2024
Navigating the complexities of commercializing cell and gene therapies (CGT) requires innovative solutions to overcome challenges such as designing effective clinical trials, implementing alternative payment models for scalability, and establishing robust supply chain platforms for advanced therapies.
The Syneos Health Cell and Gene Therapy Development Engine stands at the forefront of addressing these hurdles. With our extensive experience and expertise in CGT development and commercialization, we are poised to tackle the unique challenges facing the sector today.
Meet with Us
Join us at the Meeting on the Mesa to explore how our in-depth knowledge and insights can be harnessed to tailor solutions that meet the specific demands of your trial. Our goal is to ensure the safety and efficacy of each study, while also addressing the commercialization challenges to accelerate the delivery of groundbreaking therapies to patients.
Our Attendees
Senior Vice President & Head of Cell and Gene Therapy
Director, Business Development,
Clinical Solutions
Related Content
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
A Holistic Approach to Genetic Medicines is Next for the Life Science Industry
Exploring an Expedited Regulatory Pathway for Cell and Gene Therapies
Cell and Gene Therapy Sponsors Must Overcome Unique Hurdles to Realize Promise to Patients
Strategies for Small Biotech in the Development of Cell Therapy Trials
View more of our insights on Cell & Gene Therapy.
Learn more about our Cell & Gene Therapy expertise.
